BriaCell Therapeutics
Quarterly Financials
| Values in thousands | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | -3 | ||
EBITDA | -20,169 | -8,257 | -22,770 | -7,493 |
EBIT | -20,172 | -8,261 | -22,774 | -7,496 |
Net Income | 1,715 | -11,294 | 6,001 | -2,418 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,083 | -7,401 | -7,605 | -10,919 |
Cash | 935 | 6,244 | 13,645 | 21,251 |
Basic Shares | 16,674 | 15,981 | 16,674 | 15,518 |
Annual Financials
| Values in thousands | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15 | -15 | -15 | -13 |
EBITDA | -22,365 | -11,502 | 3,705 | 1,398 |
EBIT | -22,381 | -11,518 | 3,689 | 1,383 |
Net Income | -20,302 | -11,549 | 3,689 | 1,384 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,744 | -12,484 | -7,747 | -1,159 |
Cash | 21,251 | 41,041 | 57,268 | 19 |
Basic Shares | 15,518 | 15,494 | 4,519 | 713 |
